Clinical Trial: A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Refractory Solid Tumors
Study Type: INTERVENTIONAL
Official Title: A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
Brief Summary:
To find the recommended dose of eribulin that can be given in combination with irinotecan and temozolomide to treat relapsed and/or refractory solid tumors.
Read more